Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amgen - 42 Year Stock Price History | AMGN

Historical daily share price chart and data for Amgen since 1983 adjusted for splits and dividends. The latest closing stock price for Amgen as of May 29, 2025 is 283.54.
  • The all-time high Amgen stock closing price was 329.11 on September 20, 2024.
  • The Amgen 52-week high stock price is 346.85, which is 22.3% above the current share price.
  • The Amgen 52-week low stock price is 253.30, which is 10.7% below the current share price.
  • The average Amgen stock price for the last 52 weeks is 302.49.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Amgen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 286.6791 254.9490 324.4920 254.2700 283.5400 10.63%
2024 293.2592 283.8460 329.1120 252.7440 256.2860 -6.77%
2023 234.7975 241.3680 275.3230 201.2850 274.9020 13.46%
2022 224.0643 202.7150 267.8800 197.7610 242.2810 20.43%
2021 203.6112 196.5840 226.4500 177.8460 201.1770 0.89%
2020 198.0202 202.6400 223.3020 154.8990 199.4120 -1.99%
2019 162.9521 157.1800 205.2560 138.3380 203.4590 27.60%
2018 151.9959 140.8370 170.5720 133.1230 159.4490 15.23%
2017 134.0879 116.6690 150.9450 116.6690 138.3710 22.27%
2016 119.2815 119.4240 135.0370 103.9730 113.1700 -7.57%
2015 118.1398 118.2250 131.9110 99.2415 122.4340 3.95%
2014 96.1089 83.9977 126.9130 80.7659 117.7810 42.33%
2013 74.7865 63.4899 85.7366 58.4548 82.7501 34.80%
2012 53.9376 44.7942 64.2163 44.5497 61.3890 36.83%
2011 38.8587 38.4141 45.2344 33.3798 44.8641 18.17%
2010 38.5533 39.9147 42.2797 34.8251 37.9646 -2.95%
2009 37.9750 40.7930 44.5410 31.1946 39.1195 -2.04%
2008 35.3652 32.2250 45.5645 27.6402 39.9355 24.35%
2007 40.0561 47.3002 52.4520 32.1143 32.1143 -32.02%
2006 48.8514 55.5708 55.5708 44.2022 47.2380 -13.38%
2005 48.3713 44.4511 59.5886 39.5551 54.5335 22.93%
2004 40.7310 43.1165 45.7996 36.4433 44.3612 3.82%
2003 42.4907 34.1059 49.4716 33.8017 42.7292 27.82%
2002 34.1556 39.0019 43.2064 21.4856 33.4282 -14.35%
2001 43.0917 43.4795 51.3024 35.6204 39.0296 -11.73%
2000 45.2732 43.5227 53.9388 35.4838 44.2143 6.45%
1999 25.6592 18.5631 44.8626 18.0877 41.5346 129.77%
1998 11.5528 9.3248 18.1309 8.1470 18.0768 93.19%
1997 9.6340 9.4436 11.8208 7.9417 9.3572 -0.46%
1996 10.1152 10.0703 11.3237 8.9034 9.4004 -8.42%
1995 7.0466 5.0352 10.2648 4.8839 10.2648 101.27%
1994 4.1853 4.2464 5.1324 3.0565 5.1000 19.19%
1993 3.6349 6.1048 6.1157 2.7229 4.2788 -29.91%
1992 5.5746 6.4615 6.7208 4.3220 6.1048 -6.77%
1991 3.9052 1.8369 6.5479 1.6640 6.5479 265.05%
1990 1.1382 0.7419 1.8260 0.6447 1.7937 154.10%
1989 0.6318 0.4610 0.8644 0.4592 0.7059 45.19%
1988 0.4406 0.4646 0.5150 0.3710 0.4862 8.87%
1987 0.4645 0.3404 0.6411 0.2341 0.4466 40.93%
1986 0.2914 0.1819 0.4088 0.1801 0.3169 62.93%
1985 0.1105 0.0685 0.2089 0.0667 0.1945 169.76%
1984 0.0791 0.1044 0.1189 0.0522 0.0721 -30.94%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $149.697B $33.424B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $218.268B 16.29
Gilead Sciences (GILD) United States $134.892B 14.01
Vertex Pharmaceuticals (VRTX) United States $114.300B 0.00
Bristol Myers Squibb (BMY) United States $95.588B 6.40
GSK (GSK) United Kingdom $80.837B 9.60
CSL (CSLLY) Australia $77.058B 0.00
Regeneron Pharmaceuticals (REGN) United States $63.899B 15.51
Alnylam Pharmaceuticals (ALNY) United States $37.234B 0.00
Argenex SE (ARGX) Netherlands $35.185B 96.04
BeiGene (ONC) Cayman Islands $23.860B 0.00
BioNTech SE (BNTX) Germany $23.445B 0.00
Biogen (BIIB) United States $18.687B 8.06
Royalty Pharma (RPRX) United States $18.346B 7.75
Genmab (GNMSF) Denmark $13.859B 14.17
Genmab (GMAB) Denmark $13.587B 15.24
Illumina (ILMN) United States $13.365B 25.35
Incyte (INCY) United States $12.569B 95.49
Insmed (INSM) United States $12.087B 0.00
Exelixis (EXEL) United States $11.566B 19.63
BioMarin Pharmaceutical (BMRN) United States $11.140B 18.10
Exact Sciences (EXAS) United States $10.956B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.783B 27.54
Moderna (MRNA) United States $10.075B 0.00
QIAGEN (QGEN) Netherlands $9.865B 19.19
Ascendis Pharma (ASND) Denmark $9.709B 0.00
Roivant Sciences (ROIV) United Kingdom $7.578B 0.00
Bio-Techne Corp (TECH) United States $7.514B 28.03
Revolution Medicines (RVMD) United States $7.028B 0.00
Repligen (RGEN) United States $6.808B 76.21
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $6.767B 0.00
Halozyme Therapeutics (HALO) United States $6.707B 12.84
Jazz Pharmaceuticals (JAZZ) Ireland $6.597B 6.36
Verona Pharma American Depositary Share (VRNA) United Kingdom $6.294B 0.00
Blueprint Medicines (BPMC) United States $6.155B 0.00
Telix Pharmaceuticals (TLX) Australia $5.722B 0.00
TG Therapeutics (TGTX) United States $5.579B 146.42
Legend Biotech (LEGN) United States $5.199B 0.00
Nuvalent (NUVL) United States $5.129B 0.00
Axsome Therapeutics (AXSM) United States $5.071B 0.00
Alkermes (ALKS) Ireland $4.931B 13.23
Zealand Pharma (ZLDPF) Denmark $4.803B 0.00
Guardant Health (GH) United States $4.731B 0.00
ADMA Biologics Inc (ADMA) United States $4.658B 34.84
Vaxcyte (PCVX) United States $4.048B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.791B 0.00
PTC Therapeutics (PTCT) United States $3.747B 6.52
Avidity Biosciences (RNA) United States $3.724B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.685B 32.38
Sarepta Therapeutics (SRPT) United States $3.659B 0.00
Cytokinetics (CYTK) United States $3.616B 0.00
Akero Therapeutics (AKRO) United States $3.613B 0.00
Krystal Biotech (KRYS) United States $3.565B 27.47
SpringWorks Therapeutics (SWTX) United States $3.517B 0.00
Merus (MRUS) Netherlands $3.461B 0.00
Alvotech (ALVO) Luxembourg $3.371B 19.28
Arcellx (ACLX) United States $3.370B 0.00
Zai Lab (ZLAB) China $3.341B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.248B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.215B 0.00
Viking Therapeutics (VKTX) United States $3.047B 0.00
Metsera (MTSR) United States $2.943B 0.00
Protagonist Therapeutics (PTGX) United States $2.836B 61.00
Scholar Rock Holding (SRRK) United States $2.740B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.443B 0.00
Immunovant (IMVT) United States $2.395B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.306B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.186B 0.00
ImmunityBio (IBRX) United States $2.171B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.166B 0.00
NovoCure (NVCR) Jersey $2.159B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.149B 0.00
Ascentage Pharma Group - (AAPG) China $2.128B 0.00
Vericel (VCEL) United States $2.119B 1403.33
Apellis Pharmaceuticals (APLS) United States $2.111B 0.00
Bavarian Nordic (BVNRY) Denmark $2.056B 10.86
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.989B 0.00
Belite Bio (BLTE) United States $1.962B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.936B 12.87
Ligand Pharmaceuticals (LGND) United States $1.933B 0.00
CG Oncology (CGON) United States $1.927B 0.00
Denali Therapeutics (DNLI) United States $1.894B 0.00
Amicus Therapeutics (FOLD) United States $1.878B 203.33
Kymera Therapeutics (KYMR) United States $1.875B 0.00
Certara (CERT) United States $1.837B 34.32
Agios Pharmaceuticals (AGIO) United States $1.786B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.767B 0.00
IDEAYA Biosciences (IDYA) United States $1.713B 0.00
Twist Bioscience (TWST) United States $1.697B 0.00
Beam Therapeutics (BEAM) United States $1.697B 0.00
Apogee Therapeutics (APGE) United States $1.676B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.619B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.582B 0.00
Disc Medicine (IRON) United States $1.563B 0.00
Biohaven (BHVN) United States $1.538B 0.00
GRAIL (GRAL) United States $1.478B 0.00
Edgewise Therapeutics (EWTX) United States $1.472B 0.00
Janux Therapeutics (JANX) United States $1.402B 0.00
Mesoblast (MESO) Australia $1.399B 0.00
Adaptive Biotechnologies (ADPT) United States $1.390B 0.00
89BIO (ETNB) United States $1.347B 0.00
Travere Therapeutics (TVTX) United States $1.328B 0.00
Structure Therapeutics (GPCR) United States $1.273B 0.00
ANI Pharmaceuticals (ANIP) United States $1.252B 12.90
Celldex Therapeutics (CLDX) United States $1.239B 0.00
MannKind (MNKD) United States $1.237B 25.44
Liquidia Technologies (LQDA) United States $1.212B 0.00
Vera Therapeutics (VERA) United States $1.203B 0.00
Pacira BioSciences (PCRX) United States $1.183B 11.26
Dynavax Technologies (DVAX) United States $1.141B 67.86
BGM Group (BGM) China $1.125B 0.00
Novavax (NVAX) United States $1.121B 2.61
Anbio Biotechnology (NNNN) Germany $1.112B 0.00
Viridian Therapeutics (VRDN) United States $1.101B 0.00
Mineralys Therapeutics (MLYS) United States $1.032B 0.00
Intellia Therapeutics (NTLA) United States $1.001B 0.00
CureVac (CVAC) Germany $0.996B 4.83
Arcus Biosciences (RCUS) United States $0.967B 0.00
MiMedx (MDXG) United States $0.962B 23.25
NeoGenomics (NEO) United States $0.955B 0.00
WAVE Life Sciences (WVE) Singapore $0.933B 0.00
Geron (GERN) United States $0.924B 0.00
Spyre Therapeutics (SYRE) United States $0.909B 0.00
Gyre Therapeutics (GYRE) United States $0.885B 236.00
Syndax Pharmaceuticals (SNDX) United States $0.871B 0.00
Niagen Bioscience (NAGE) United States $0.865B 122.00
Oculis Holding AG (OCS) Switzerland $0.856B 0.00
CorMedix Inc (CRMD) United States $0.843B 56.50
UniQure (QURE) Netherlands $0.824B 0.00
Pharvaris (PHVS) Netherlands $0.808B 0.00
LENZ Therapeutics (LENZ) United States $0.808B 0.00
Zymeworks (ZYME) United States $0.781B 0.00
Nurix Therapeutics (NRIX) United States $0.765B 0.00
Praxis Precision Medicines (PRAX) United States $0.754B 0.00
Immunome (IMNM) United States $0.751B 0.00
Nuvation Bio (NUVB) United States $0.749B 0.00
ArriVent BioPharma (AVBP) United States $0.686B 0.00
Pharming Group (PHAR) Netherlands $0.682B 0.00
Pharming Group (PHGUF) Netherlands $0.671B 0.00
Vir Biotechnology (VIR) United States $0.658B 0.00
GH Research (GHRS) Ireland $0.654B 0.00
Arbutus Biopharma (ABUS) United States $0.653B 0.00
Replimune (REPL) United States $0.650B 0.00
Anavex Life Sciences (AVXL) United States $0.647B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.640B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.626B 0.00
Trevi Therapeutics (TRVI) United States $0.625B 0.00
Immatics (IMTX) Germany $0.625B 0.00
AnaptysBio (ANAB) United States $0.614B 0.00
AbCellera Biologics (ABCL) Canada $0.609B 0.00
Keros Therapeutics (KROS) United States $0.595B 0.00
Iovance Biotherapeutics (IOVA) United States $0.584B 0.00
Dianthus Therapeutics (DNTH) United States $0.569B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.568B 0.00
Sionna Therapeutics (SION) United States $0.562B 0.00
Cogent Biosciences (COGT) United States $0.556B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.540B 0.00
Eton Pharmaceuticals (ETON) United States $0.539B 0.00
Arvinas (ARVN) United States $0.532B 0.00
Opthea (OPT) Australia $0.525B 0.00
Bicara Therapeutics (BCAX) United States $0.516B 0.00
Stoke Therapeutics (STOK) United States $0.515B 11.94
Sana Biotechnology (SANA) United States $0.507B 0.00
Maze Therapeutics (MAZE) United States $0.503B 0.00
Upstream Bio (UPB) United States $0.496B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.484B 0.00
Kura Oncology (KURA) United States $0.480B 0.00
Tyra Biosciences (TYRA) United States $0.477B 0.00
Castle Biosciences (CSTL) United States $0.469B 31.82
Cullinan Therapeutics (CGEM) United States $0.463B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.439B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.434B 0.00
Septerna (SEPN) United States $0.433B 0.00
REGENXBIO (RGNX) United States $0.428B 0.00
PureTech Health (PRTC) United States $0.428B 0.00
Oric Pharmaceuticals (ORIC) United States $0.424B 0.00
MBX Biosciences (MBX) United States $0.418B 0.00
Verastem (VSTM) United States $0.418B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.416B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.415B 0.00
Benitec Biopharma (BNTC) United States $0.413B 0.00
MeiraGTx Holdings (MGTX) United States $0.410B 0.00
Humacyte (HUMA) United States $0.408B 0.00
Sage Therapeutics (SAGE) United States $0.406B 0.00
Precigen (PGEN) United States $0.404B 0.00
Tectonic Therapeutic (TECX) United States $0.402B 0.00
Myriad Genetics (MYGN) United States $0.399B 0.00
Celcuity (CELC) United States $0.398B 0.00
Kamada (KMDA) Israel $0.396B 23.76
Northwest Biotherapeutics (NWBO) United States $0.386B 0.00
Zenas BioPharma (ZBIO) United States $0.386B 0.00
ITeos Therapeutics (ITOS) United States $0.385B 0.00
Fortrea Holdings (FTRE) United States $0.378B 10.45
ATyr Pharma (ATYR) United States $0.374B 0.00
Fulcrum Therapeutics (FULC) United States $0.372B 0.00
Vigil Neuroscience (VIGL) United States $0.368B 0.00
Checkpoint Therapeutics (CKPT) United States $0.368B 0.00
Abivax SA (ABVX) France $0.360B 0.00
Emergent Biosolutions (EBS) United States $0.353B 0.00
Absci (ABSI) United States $0.350B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.348B 0.00
Rapport Therapeutics (RAPP) United States $0.347B 0.00
Olema Pharmaceuticals (OLMA) United States $0.339B 0.00
Rezolute (RZLT) United States $0.338B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.321B 0.00
Cytek Biosciences (CTKB) United States $0.315B 0.00
Inventiva S.A (IVA) France $0.315B 0.00
Erasca (ERAS) United States $0.312B 0.00
Alpha Teknova (TKNO) United States $0.310B 0.00
Abeona Therapeutics (ABEO) United States $0.306B 0.00
Aura Biosciences (AURA) United States $0.302B 0.00
XOMA Royalty (XOMA) United States $0.301B 0.00
Candel Therapeutics (CADL) United States $0.298B 0.00
Entrada Therapeutics (TRDA) United States $0.295B 9.59
Compass Therapeutics (CMPX) United States $0.290B 0.00
Tvardi Therapeutics (TVRD) United States $0.289B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.285B 0.00
Cidara Therapeutics (CDTX) United States $0.285B 0.00
Prima BioMed (IMMP) Australia $0.282B 0.00
Terns Pharmaceuticals (TERN) United States $0.267B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.265B 0.00
Gossamer Bio (GOSS) United States $0.264B 0.00
Palvella Therapeutics (PVLA) United States $0.263B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.263B 0.00
Ocugen (OCGN) United States $0.258B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.258B 0.00
DBV Technologies S.A (DBVT) France $0.256B 0.00
Lifecore Biomedical (LFCR) United States $0.255B 0.00
Inozyme Pharma (INZY) United States $0.255B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.254B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.253B 0.00
Solid Biosciences (SLDB) United States $0.253B 0.00
Neurogene (NGNE) United States $0.252B 0.00
Atea Pharmaceuticals (AVIR) United States $0.251B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.250B 50.75
Allogene Therapeutics (ALLO) United States $0.249B 0.00
Prothena (PRTA) Ireland $0.248B 0.00
Astria Therapeutics (ATXS) United States $0.247B 0.00
MaxCyte (MXCT) United States $0.241B 0.00
Semper Paratus Acquisition (TVGN) United States $0.241B 0.00
Foghorn Therapeutics (FHTX) United States $0.240B 0.00
Cartesian Therapeutics (RNAC) United States $0.236B 0.00
Amarin (AMRN) Ireland $0.234B 0.00
Third Harmonic Bio (THRD) United States $0.234B 0.00
ACELYRIN, INC (SLRN) United States $0.229B 0.00
Design Therapeutics (DSGN) United States $0.227B 0.00
Adherex Technologies (FENC) United States $0.224B 0.00
Annexon (ANNX) United States $0.223B 0.00
Aardvark Therapeutics (AARD) United States $0.222B 0.00
GENFIT S.A (GNFT) France $0.216B 0.00
Adocia (ADOCY) France $0.213B 0.00
Cardiff Oncology (CRDF) United States $0.212B 0.00
Actuate Therapeutics (ACTU) United States $0.212B 0.00
Tango Therapeutics (TNGX) United States $0.210B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.209B 0.00
EnGene Holdings (ENGN) Canada $0.203B 0.00
Nuvectis Pharma (NVCT) United States $0.202B 0.00
Monopar Therapeutics (MNPR) United States $0.199B 0.00
Innate Pharma S.A (IPHA) France $0.197B 0.00
BioStem Technologies (BSEM) $0.195B 7.92
CytomX Therapeutics (CTMX) United States $0.193B 5.00
Codexis (CDXS) United States $0.193B 0.00
Bright Minds Biosciences (DRUG) United States $0.193B 0.00
CARGO Therapeutics (CRGX) United States $0.190B 0.00
ScPharmaceuticals (SCPH) United States $0.189B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.189B 0.00
Inhibrx Biosciences (INBX) United States $0.187B 0.11
Urogen Pharma (URGN) United States $0.187B 0.00
Alumis (ALMS) United States $0.186B 0.00
Kodiak Sciences (KOD) United States $0.185B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.179B 0.00
DiaMedica Therapeutics (DMAC) United States $0.178B 0.00
Galena Biopharma (SLS) United States $0.178B 0.00
Instil Bio (TIL) United States $0.175B 0.00
INmune Bio (INMB) United States $0.169B 0.00
AC Immune (ACIU) Switzerland $0.169B 0.00
Puma Biotechnology (PBYI) United States $0.167B 4.38
Prime Medicine (PRME) United States $0.167B 0.00
Molecular Partners AG (MOLN) Switzerland $0.164B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.162B 0.00
Anika Therapeutics (ANIK) United States $0.159B 0.00
Editas Medicine (EDIT) United States $0.157B 0.00
Voyager Therapeutics (VYGR) United States $0.151B 0.00
Fate Therapeutics (FATE) United States $0.146B 0.00
BioAge Labs (BIOA) United States $0.143B 0.00
Alector (ALEC) United States $0.142B 0.00
TuHURA Biosciences (HURA) United States $0.140B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.139B 0.00
Alpha Cognition (ACOG) Canada $0.135B 0.00
Spero Therapeutics (SPRO) United States $0.131B 0.00
Greenwich LifeSciences (GLSI) United States $0.130B 0.00
Compugen (CGEN) Israel $0.129B 0.00
Rapt Therapeutics (RAPT) United States $0.129B 0.00
Ventyx Biosciences (VTYX) United States $0.126B 0.00
Nkarta (NKTX) United States $0.125B 0.00
Elicio Therapeutics (ELTX) United States $0.123B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.123B 0.00
Theratechnologies (THTX) Canada $0.119B 0.00
EXoZymes (EXOZ) United States $0.117B 0.00
Seer (SEER) United States $0.117B 0.00
Neumora Therapeutics (NMRA) United States $0.116B 0.00
Black Diamond Therapeutics (BDTX) United States $0.113B 33.17
Orchestra BioMed Holdings (OBIO) United States $0.113B 0.00
Kyverna Therapeutics (KYTX) United States $0.110B 0.00
Sangamo Therapeutics (SGMO) United States $0.105B 0.00
BioHarvest Sciences (BHST) Canada $0.104B 0.00
Sagimet Biosciences (SGMT) United States $0.104B 0.00
Caribou Biosciences (CRBU) United States $0.104B 0.00
Invivyd (IVVD) United States $0.101B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.097B 0.00
I-Mab (IMAB) United States $0.096B 0.00
Cabaletta Bio (CABA) United States $0.095B 0.00
Nautilus Biotechnology (NAUT) United States $0.094B 0.00
Coya Therapeutics (COYA) United States $0.094B 0.00
Coherus BioSciences (CHRS) United States $0.093B 0.00
Genelux (GNLX) United States $0.092B 0.00
HilleVax (HLVX) United States $0.092B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.090B 0.00
C4 Therapeutics (CCCC) United States $0.089B 0.00
XBiotech (XBIT) United States $0.089B 0.00
Contineum Therapeutics (CTNM) United States $0.088B 0.00
Immunic (IMUX) United States $0.087B 0.00
Adagene (ADAG) China $0.087B 0.00
Climb Bio (CLYM) United States $0.084B 0.00
Senti Biosciences (SNTI) United States $0.084B 0.00
Entera Bio (ENTX) Israel $0.083B 0.00
Pliant Therapeutics (PLRX) United States $0.083B 0.00
Agenus (AGEN) United States $0.083B 0.00
TScan Therapeutics (TCRX) United States $0.082B 0.00
Whitehawk Therapeutics (WHWK) United States $0.082B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.082B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.081B 0.00
Genenta Science S.p.A (GNTA) Italy $0.079B 0.00
IO Biotech (IOBT) Denmark $0.078B 0.00
Cellectis S.A (CLLS) France $0.078B 0.00
23andMe Holding (MEHCQ) United States $0.078B 0.00
Sutro Biopharma (STRO) United States $0.077B 0.00
Jasper Therapeutics (JSPR) United States $0.077B 0.00
IGM Biosciences (IGMS) United States $0.074B 0.00
Alto Neuroscience (ANRO) United States $0.074B 0.00
Inovio Pharmaceuticals (INO) United States $0.073B 0.00
VistaGen Therapeutics (VTGN) United States $0.073B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.072B 0.00
Tenaya Therapeutics (TNYA) United States $0.072B 0.00
Elutia (ELUT) United States $0.071B 0.00
MediciNova (MNOV) United States $0.070B 0.00
Adlai Nortye (ANL) Cayman Islands $0.069B 0.00
CervoMed (CRVO) United States $0.068B 0.00
Zura Bio (ZURA) United States $0.068B 0.00
BeyondSpring (BYSI) United States $0.067B 0.00
Immuneering (IMRX) United States $0.065B 0.00
Citius Oncology (CTOR) United States $0.064B 0.00
Forte Biosciences (FBRX) United States $0.064B 0.00
Exicure (XCUR) United States $0.063B 0.00
PDS Biotechnology (PDSB) United States $0.063B 0.00
OKYO Pharma (OKYO) $0.063B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.062B 0.00
Skye Bioscience (SKYE) United States $0.062B 0.00
Seres Therapeutics (MCRB) United States $0.062B 0.00
Clearside Biomedical (CLSD) United States $0.061B 0.00
Akoya Biosciences (AKYA) United States $0.061B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Opus Genetics (IRD) United States $0.060B 0.00
ZIVO Bioscience (ZIVO) United States $0.060B 0.00
Repare Therapeutics (RPTX) Canada $0.059B 0.00
Celularity (CELU) United States $0.056B 0.00
Fortress Biotech (FBIO) United States $0.056B 0.00
Medicus Pharma (MDCX) United States $0.056B 0.00
Ikena Oncology (IKNA) United States $0.056B 0.00
Precision BioSciences (DTIL) United States $0.055B 0.00
TELA Bio (TELA) United States $0.055B 0.00
Werewolf Therapeutics (HOWL) United States $0.055B 0.00
Oncobiologics (OTLK) United States $0.055B 0.00
Immix Biopharma (IMMX) United States $0.054B 0.00
Kalaris Therapeutics (KLRS) United States $0.054B 0.00
Renovaro (RENB) United States $0.054B 0.00
Adicet Bio (ACET) United States $0.054B 0.00
Applied Therapeutics (APLT) United States $0.053B 0.00
VTv Therapeutics (VTVT) United States $0.053B 0.00
Biomea Fusion (BMEA) United States $0.052B 0.00
PepGen (PEPG) United States $0.052B 0.00
Shattuck Labs (STTK) United States $0.050B 0.00
InflaRx (IFRX) Germany $0.049B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
Xilio Therapeutics (XLO) United States $0.049B 0.00
Quince Therapeutics (QNCX) United States $0.048B 0.00
Cue Biopharma (CUE) United States $0.048B 0.00
RenovoRx (RNXT) United States $0.047B 0.00
Annovis Bio (ANVS) United States $0.047B 0.00
Artiva Biotherapeutics (ARTV) United States $0.047B 0.00
Atara Biotherapeutics (ATRA) United States $0.046B 0.00
Adverum Biotechnologies (ADVM) United States $0.046B 0.00
Mersana Therapeutics (MRSN) United States $0.046B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.044B 0.00
Rein Therapeutics (RNTX) United States $0.043B 0.00
Connect Biopharma Holdings (CNTB) United States $0.043B 0.00
CAMP4 Therapeutics (CAMP) United States $0.042B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.042B 0.00
Kronos Bio (KRON) United States $0.041B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.039B 0.00
Alterity Therapeutics - (ATHE) Australia $0.039B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.038B 0.00
Scilex Holding (SCLX) United States $0.037B 0.00
Pluri (PLUR) Israel $0.036B 0.00
Rani Therapeutics Holdings (RANI) United States $0.036B 0.00
Aligos Therapeutics (ALGS) United States $0.035B 0.00
Radiopharm Theranostics - (RADX) Australia $0.035B 0.00
Estrella Immunopharma (ESLA) United States $0.035B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.035B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.035B 0.00
AN2 Therapeutics (ANTX) United States $0.035B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.035B 0.00
OnKure Therapeutics (OKUR) United States $0.033B 0.00
Oncolytics Biotech (ONCY) Canada $0.033B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.032B 0.00
Quantum Biopharma (QNTM) Canada $0.032B 0.00
Lantern Pharma (LTRN) United States $0.031B 0.00
Dyadic (DYAI) United States $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
FibroBiologics (FBLG) United States $0.030B 0.00
Kezar Life Sciences (KZR) United States $0.030B 0.00
Grace Therapeutics (GRCE) Canada $0.029B 0.00
Femasys (FEMY) United States $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.027B 0.00
Cadrenal Therapeutics (CVKD) United States $0.027B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.027B 0.00
Boundless Bio (BOLD) United States $0.027B 0.00
Imunon (IMNN) United States $0.027B 0.00
Dare Bioscience (DARE) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.025B 0.00
Advanced Biomed (ADVB) United States $0.025B 0.00
Generation Bio (GBIO) United States $0.025B 0.00
KALA BIO (KALA) United States $0.025B 0.00
CalciMedica (CALC) United States $0.025B 0.00
ALX Oncology Holdings (ALXO) United States $0.024B 0.00
Clene (CLNN) United States $0.024B 0.00
ABVC BioPharma (ABVC) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
BioAtla (BCAB) United States $0.023B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.023B 0.00
Passage Bio (PASG) United States $0.022B 0.00
Q32 Bio (QTTB) United States $0.022B 0.00
Vor Biopharma (VOR) $0.022B 0.00
Curis (CRIS) United States $0.022B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.022B 0.00
Ovid Therapeutics (OVID) United States $0.021B 0.00
Chemomab Therapeutics (CMMB) Israel $0.020B 0.00
HOOKIPA Pharma (HOOK) United States $0.019B 0.00
Longeveron (LGVN) United States $0.019B 0.00
X4 Pharmaceuticals (XFOR) United States $0.019B 0.00
Elevation Oncology (ELEV) United States $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.018B 0.00
Cingulate (CING) United States $0.017B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
SAB Biotherapeutics (SABS) United States $0.016B 0.00
Leap Therapeutics (LPTX) United States $0.016B 0.00
GeoVax Labs (GOVX) United States $0.016B 0.00
Gelteq (GELS) Australia $0.016B 0.00
Promis Neurosciences (PMN) Canada $0.016B 0.00
Abpro Holdings (ABP) United States $0.016B 0.00
Cognition Therapeutics (CGTX) United States $0.015B 0.00
MetaVia (MTVA) United States $0.014B 0.00
Rallybio (RLYB) United States $0.014B 0.00
Allarity Therapeutics (ALLR) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Equillium (EQ) United States $0.013B 0.00
Synlogic (SYBX) United States $0.013B 0.00
IBio (IBIO) United States $0.013B 0.00
Biorestorative Therapies (BRTX) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.013B 0.00
IN8bio (INAB) United States $0.013B 0.00
Moleculin Biotech (MBRX) United States $0.013B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.012B 0.00
Aytu BioPharma (AYTU) United States $0.012B 0.00
BRIACELL THERAP (BCTX) Canada $0.012B 0.00
UNITY Biotechnology (UBX) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
HCW Biologics (HCWB) United States $0.012B 0.00
Athira Pharma (ATHA) United States $0.011B 0.00
Hoth Therapeutics (HOTH) United States $0.011B 0.00
BioAffinity Technologies (BIAF) United States $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Dogwood Therapeutics (DWTX) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
LakeShore Biopharma (LSB) China $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.008B 0.00
Portage Biotech (PRTG) $0.008B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
BioXcel Therapeutics (BTAI) United States $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Sensei Biotherapeutics (SNSE) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Avalon GloboCare (ALBT) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Intensity Therapeutics (INTS) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Mustang Bio (MBIO) United States $0.006B 0.00
Polyrizon (PLRZ) Israel $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Eyenovia (EYEN) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Novogen (KZIA) Australia $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Synaptogenix (SNPX) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Silo Pharma (SILO) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Capstone Therapeutics (CAPS) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00